Sitaxentan in Pulmonary Arterial Hypertension: A Viewpoint by Steven Kawut

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.5, 2007-01, pp. : 771-772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitaxentan: In Pulmonary Arterial Hypertension

By Scott Lesley J.

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 761-770

Adis International

Access to resources Recommend Favorite

Sitaxentan: a guide to its use in pulmonary arterial hypertension

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 9, 2007-09 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Encysive Pharmaceuticals has announced the launch of sitaxentan [Thelin] in France for the treatment of pulmonary arterial hypertension

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Tadalafil: In Pulmonary Arterial Hypertension

By Croxtall Jamie D. Lyseng-Williamson Katherine A.

Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. : 479-488

Adis International

Access to resources Recommend Favorite

Terguride for pulmonary arterial hypertension

By Antoniu Sabina A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1333-1335

Informa Healthcare

Access to resources Recommend Favorite